Cargando…
PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429737/ http://dx.doi.org/10.1097/01.HS9.0000975660.56238.59 |
| _version_ | 1785090786238398464 |
|---|---|
| author | Ogbogu, Princess Klion, Amy Roufosse, Florence Akuthota, Praveen Khoury, Paneez Shih, Vivian Griffis, Dianne Parikh, Himanshu Chen, Ron Fan, Ying Mayer, Gaell Jain, Priya Katial, Rohit Psallidas, Ioannis |
| author_facet | Ogbogu, Princess Klion, Amy Roufosse, Florence Akuthota, Praveen Khoury, Paneez Shih, Vivian Griffis, Dianne Parikh, Himanshu Chen, Ron Fan, Ying Mayer, Gaell Jain, Priya Katial, Rohit Psallidas, Ioannis |
| author_sort | Ogbogu, Princess |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429737 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104297372023-08-17 PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME Ogbogu, Princess Klion, Amy Roufosse, Florence Akuthota, Praveen Khoury, Paneez Shih, Vivian Griffis, Dianne Parikh, Himanshu Chen, Ron Fan, Ying Mayer, Gaell Jain, Priya Katial, Rohit Psallidas, Ioannis Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429737/ http://dx.doi.org/10.1097/01.HS9.0000975660.56238.59 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Ogbogu, Princess Klion, Amy Roufosse, Florence Akuthota, Praveen Khoury, Paneez Shih, Vivian Griffis, Dianne Parikh, Himanshu Chen, Ron Fan, Ying Mayer, Gaell Jain, Priya Katial, Rohit Psallidas, Ioannis PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME |
| title | PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME |
| title_full | PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME |
| title_fullStr | PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME |
| title_full_unstemmed | PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME |
| title_short | PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME |
| title_sort | pb2229: a phase 3 study evaluating the efficacy and safety of benralizumab in patients with hypereosinophilic syndrome |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429737/ http://dx.doi.org/10.1097/01.HS9.0000975660.56238.59 |
| work_keys_str_mv | AT ogboguprincess pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT klionamy pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT roufosseflorence pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT akuthotapraveen pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT khourypaneez pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT shihvivian pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT griffisdianne pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT parikhhimanshu pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT chenron pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT fanying pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT mayergaell pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT jainpriya pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT katialrohit pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome AT psallidasioannis pb2229aphase3studyevaluatingtheefficacyandsafetyofbenralizumabinpatientswithhypereosinophilicsyndrome |